418 results on '"Cuezva, José M."'
Search Results
52. Overexpression of Akt converts radial growth melanoma to vertical growth melanoma
53. Efficient execution of cell death in non-glycolytic cells requires the generation of ROS controlled by the activity of mitochondrial H+-ATP synthase
54. Breast carcinomas fulfill the Warburg hypothesis and provide metabolic markers of cancer prognosis
55. Exploiting the passenger ACO1-deficiency arising from 9p21 deletions to kill T-cell lymphoblastic neoplasia cells
56. The bioenergetic signature of lung adenocarcinomas is a molecular marker of cancer diagnosis and prognosis
57. Changes in the Turnover of the Cellular Proteome during Metabolic Reprogramming: A Role for mtROS in Proteostasis
58. The bioenergetic signature of isogenic colon cancer cells predicts the cell death response to treatment with 3-bromopyruvate, iodoacetate or 5-fluorouracil
59. MYC Induces a Hybrid Energetics Program Early in Cell Reprogramming
60. Mitochondrial complex I activity signals antioxidant response through ERK5
61. MYC Induces a Hybrid Energetics Program Early in Cell Reprogramming
62. A review of the inhibition of the mitochondrial ATP synthase by IF1 in vivo: Reprogramming energy metabolism and inducing mitohormesis
63. PD-1 signaling affects cristae morphology and leads to mitochondrial dysfunction in human CD8+ T lymphocytes.
64. A Review of the Inhibition of the Mitochondrial ATP Synthase by IF1 in vivo: Reprogramming Energy Metabolism and Inducing Mitohormesis
65. Tissue‐specific expression and post‐transcriptional regulation of the ATPase inhibitory factor 1 (IF1) in human and mouse tissues
66. Dysfunction of the immune system in conditional IF1 (Atp5if1) knockout mice in colon
67. Mitochondrial Complex I activity signals antioxidant response through ERK5
68. The Role of Mitochondrial H+-ATP Synthase in Cancer
69. The mitochondrial ATP synthase is a shared drug target for aging and dementia
70. Plasma metabolome and skin proteins in Charcot-Marie-Tooth 1A patients
71. Overexpression of the ATPase Inhibitory Factor 1 Favors a Non-metastatic Phenotype in Breast Cancer
72. Hif-1α Knockdown Reduces Glycolytic Metabolism and Induces Cell Death of Human Synovial Fibroblasts Under Normoxic Conditions
73. Plasma metabolome and skin proteins in Charcot-Marie-Tooth 1A patients
74. Mitochondrial ROS Production Protects the Intestine from Inflammation through Functional M2 Macrophage Polarization
75. Overexpression of the ATPase Inhibitory Factor 1 Favors a Non-metastatic Phenotype in Breast Cancer
76. Pyruvate kinase M2 and the mitochondrial ATPase Inhibitory Factor 1 provide novel biomarkers of dermatomyositis: a metabolic link to oncogenesis
77. Tissue-specific expression and post-transcriptional regulation of the ATPase inhibitory factor 1 (IF1) in human and mouse tissues.
78. RNA-binding proteins regulate cell respiration and coenzyme Q biosynthesis by post-transcriptional regulation of COQ7
79. ATPase Inhibitory Factor 1 (IF1): A main driver of metabolic reprogramming and nuclear signaling in cancer
80. The ATPase Inhibitory Factor 1 (IF1): A master regulator of energy metabolism and of cell survival
81. RNA-binding proteins regulate cell respiration and coenzyme Q biosynthesis by post-transcriptional regulation ofCOQ7
82. Quantitative analysis of proteins of metabolism by reverse phase protein microarrays identifies potential biomarkers of rare neuromuscular diseases
83. Down-regulation of oxidative phosphorylation in the liver by expression of the ATPase inhibitory factor 1 induces a tumor-promoter metabolic state
84. Sensitivity to anti-Fas is independent of increased cathepsin D activity and adrenodoxin reductase expression occurring in NOS-3 overexpressing HepG2 cells
85. Down-regulation of oxidative phosphorylation in the liver by expression of the ATPase inhibitory factor 1 induces a tumor-promoter metabolic state
86. The Role of Mitochondrial H+-ATP Synthase in Cancer.
87. Coenzyme Q biosynthesis is regulated by RNA-protein interaction
88. PKA Phosphorylates the ATPase Inhibitory Factor 1 and Inactivates Its Capacity to Bind and Inhibit the Mitochondrial H+-ATP Synthase
89. Adalimumab Reduces Photoreceptor Cell Death in A Mouse Model of Retinal Degeneration
90. Sensitivity to anti-Fas is independent of increased cathepsin D activity and adrenodoxin reductase expression occurring in NOS-3 overexpressing HepG2 cells
91. Lack of GDAP1 Induces Neuronal Calcium and Mitochondrial Defects in a Knockout Mouse Model of Charcot-Marie-Tooth Neuropathy
92. Quantitative analysis of proteins of metabolism by reverse phase protein microarrays identifies potential biomarkers of rare neuromuscular diseases
93. Short-term exposure of nontumorigenic human bronchial epithelial cells to carcinogenic chromium(VI) compromises their respiratory capacity and alters their bioenergetic signature
94. Cancer Abolishes the Tissue Type-Specific Differences in the Phenotype of Energetic Metabolism1
95. Biogenesis and Dynamics of Mitochondria during the Cell Cycle: Significance of 39UTRs
96. Mitochondria in cancer biology
97. Efficient execution of cell death in non-glycolytic cells requires the generation of ROS controlled by the activity of mitochondrial H+-ATP synthase
98. The H+-ATP synthase: A gate to ROS-mediated cell death or cell survival
99. Short-term exposure of nontumorigenic human bronchial epithelial cells to carcinogenic chromium(VI) compromises their respiratory capacity and alters their bioenergetic signature
100. Expression, regulation and clinical relevance of the ATPase inhibitory factor 1 in human cancers
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.